Shares of Oxford BioDynamics Plc (LON:OBD – Get Free Report) crossed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of GBX 0.11 and traded as low as GBX 0.10. Oxford BioDynamics shares last traded at GBX 0.10, with a volume of 15,910,690 shares.
Oxford BioDynamics Stock Performance
The company has a quick ratio of 2.80, a current ratio of 2.01 and a debt-to-equity ratio of 131.61. The company has a 50 day simple moving average of GBX 0.11 and a 200-day simple moving average of GBX 0.18. The stock has a market capitalization of £14.38 million, a price-to-earnings ratio of -0.53 and a beta of 0.42.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Further Reading
- Five stocks we like better than Oxford BioDynamics
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
